Literature DB >> 33572939

Functional Role of B Cells in Atherosclerosis.

Shelby D Ma1, Marion Mussbacher2, Elena V Galkina1.   

Abstract

Atherosclerosis is a lipid-driven inflammatory disease of blood vessels, and both innate and adaptive immune responses are involved in its development. The impact of B cells on atherosclerosis has been demonstrated in numerous studies and B cells have been found in close proximity to atherosclerotic plaques in humans and mice. B cells exert both atheroprotective and pro-atherogenic functions, which have been associated with their B cell subset attribution. While B1 cells and marginal zone B cells are considered to protect against atherosclerosis, follicular B cells and innate response activator B cells have been shown to promote atherosclerosis. In this review, we shed light on the role of B cells from a different, functional perspective and focus on the three major B cell functions: antibody production, antigen presentation/T cell interaction, and the release of cytokines. All of these functions have the potential to affect atherosclerosis by multiple ways and are dependent on the cellular milieu and the activation status of the B cell. Moreover, we discuss B cell receptor signaling and the mechanism of B cell activation under atherosclerosis-prone conditions. By summarizing current knowledge of B cells in and beyond atherosclerosis, we are pointing out open questions and enabling new perspectives.

Entities:  

Keywords:  B cells; adaptive immune system; atherosclerosis

Year:  2021        PMID: 33572939      PMCID: PMC7911276          DOI: 10.3390/cells10020270

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  201 in total

1.  Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.

Authors:  M K Chang; C Bergmark; A Laurila; S Hörkkö; K H Han; P Friedman; E A Dennis; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 2.  B cell antigen receptor signaling 101.

Authors:  Joseph M Dal Porto; Stephen B Gauld; Kevin T Merrell; David Mills; Aimee E Pugh-Bernard; John Cambier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

3.  Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet.

Authors:  Meritxell Nus; Andrew P Sage; Yuning Lu; Leanne Masters; Brian Y H Lam; Stephen Newland; Sandra Weller; Dimitrios Tsiantoulas; Juliette Raffort; Damiënne Marcus; Alison Finigan; Lauren Kitt; Nichola Figg; Reinhold Schirmbeck; Manfred Kneilling; Giles S H Yeo; Christoph J Binder; José Luis de la Pompa; Ziad Mallat
Journal:  Nat Med       Date:  2017-04-17       Impact factor: 53.440

4.  B-cell aortic homing and atheroprotection depend on Id3.

Authors:  Amanda C Doran; Michael J Lipinski; Stephanie N Oldham; James C Garmey; Kirsti A Campbell; Marcus D Skaflen; Alexis Cutchins; Daniel J Lee; David K Glover; Kimberly A Kelly; Elena V Galkina; Klaus Ley; Joseph L Witztum; Sotirios Tsimikas; Timothy P Bender; Coleen A McNamara
Journal:  Circ Res       Date:  2011-10-27       Impact factor: 17.367

5.  Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation.

Authors:  A N Klimov; A D Denisenko; A V Popov; V A Nagornev; V M Pleskov; A G Vinogradov; T V Denisenko; G M Kheifes; A S Kuznetzov
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162

6.  The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production.

Authors:  Byoung-gon Moon; Satoshi Takaki; Kensuke Miyake; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 7.  Differential impact of Toll-like receptor signaling on distinct B cell subpopulations.

Authors:  Almut Meyer-Bahlburg; David J Rawlings
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 8.  Getting to the Heart of the Matter: The Role of Regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis.

Authors:  Caraugh J Albany; Silvia C Trevelin; Giulio Giganti; Giovanna Lombardi; Cristiano Scottà
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

9.  Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development.

Authors:  Kyoko Hayakawa; Masanao Asano; Susan A Shinton; Ming Gui; Li-Jun Wen; Joni Dashoff; Richard R Hardy
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

Review 10.  Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?

Authors:  Katelyn Jones; Anca F Savulescu; Frank Brombacher; Sabelo Hadebe
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

View more
  10 in total

1.  High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm.

Authors:  Peicong Ge; Chenglong Liu; Liujia Chan; Yuheng Pang; Hao Li; Qian Zhang; Xun Ye; Jia Wang; Rong Wang; Yan Zhang; Wenjing Wang; Dong Zhang; Jizong Zhao
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 2.  Atherosclerosis and multi-organ-associated pathologies.

Authors:  W Coles Keeter; Shelby Ma; Natalie Stahr; Alina K Moriarty; Elena V Galkina
Journal:  Semin Immunopathol       Date:  2022-03-03       Impact factor: 11.759

3.  Circulating Autoantibodies Recognizing Immunodominant Epitopes From Human Apolipoprotein B Associate With Cardiometabolic Risk Factors, but Not With Atherosclerotic Disease.

Authors:  Timoteo Marchini; Sara Malchow; Lourdes Caceres; Abed Al Hadi El Rabih; Sophie Hansen; Timothy Mwinyella; Lisa Spiga; Sven Piepenburg; Hauke Horstmann; Tijani Olawale; Xiaowei Li; Lucia Sol Mitre; Mark Colin Gissler; Heiko Bugger; Andreas Zirlik; Timo Heidt; Ingo Hilgendorf; Peter Stachon; Constantin von Zur Muehlen; Christoph Bode; Dennis Wolf
Journal:  Front Cardiovasc Med       Date:  2022-04-11

Review 4.  Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease.

Authors:  Natalie Stahr; Elena V Galkina
Journal:  Front Cardiovasc Med       Date:  2022-07-06

5.  Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis.

Authors:  Kuang-Yuh Chyu; Xiaoning Zhao; Jianchang Zhou; Paul C Dimayuga; Nicole Wm Lio; Bojan Cercek; Noah T Trac; Eun Ji Chung; Prediman K Shah
Journal:  JCI Insight       Date:  2022-06-08

Review 6.  Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond.

Authors:  Peter Libby
Journal:  Cells       Date:  2021-04-20       Impact factor: 6.600

Review 7.  Immunotherapeutic Strategies in Cancer and Atherosclerosis-Two Sides of the Same Coin.

Authors:  Felix Sebastian Nettersheim; Felix Simon Ruben Picard; Friedrich Felix Hoyer; Holger Winkels
Journal:  Front Cardiovasc Med       Date:  2022-01-13

8.  Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Dyslipidemia.

Authors:  Da-Ming Xu; Qian Li; Jing-Xing Yi; Xin-Jian Cai; Long Xie; Wei Fang; Jin-Feng Qiu; Cheng-Wei Xu; Chun-Ling He; Xian-Ru Xu; Jie-Song Xu; Jun Yin
Journal:  Int J Gen Med       Date:  2021-09-14

9.  Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study.

Authors:  Tian Yu; Baofeng Xu; Meihua Bao; Yuanyuan Gao; Qiujuan Zhang; Xuejiao Zhang; Rui Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-16       Impact factor: 6.055

10.  Inflammation and Atherosclerosis.

Authors:  Klaus Ley
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.